Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-07 · accession 0001846487-24-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-07 | 2024-03-07 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $66.71 | -2,110 | 85.3K | -2% | -$140.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | F | D | 2,110 | $66.71 | 85,277 | D | — | — |